Kay G. Balster

Kay G. Balster

Kay Balster is one of High-Tech Gründerfonds’s longest-serving employees. Since 2009 he has been focusing on financing start-ups from the biotechnology and medical technology sectors. He can draw on 20 years of experience in advising technology start-ups, while his background in economics, training as a banker and especially the day-to-day interaction he has with the founders in his HTGF portfolio help him in his role.

When he is not working, family time and sport are his top priorities.


+49 – (0)228 – 82300 – 111



15. June 2021
Franken Finance Festival | Medical Valley
In the event Franken Finance Festival 2021 organized by Medical Valley, all relevant questions of startups/founders related to the topic of finance will be answered. Startups will be informed about different financing models and startup projects. Topics: Financing, Digital Nomads Additional workshops: “Legal & Tax” and “Intellectual Property” Date: 15.06.2021 Time: 08:30 to 17:15 Speaker and consultant from HTGF: Kay G. Balster (Principal/Authorized representative) Li

Posts & mentions

21. October 2020

Successful exit for High-Tech Gründerfonds and Evonik Venture Capital – Synoste Oy becomes part of Globus Medical

Globus Medical, based in Audubon, Pennsylvania, USA, is a leading medical device manufacturerThe Finnish start-up Synoste, with offices in Helsinki and Düsseldorf, develops high-tech implants for minimally invasive treatment of leg length discrepancyThe transaction marks HTGF’s 11th successful exit during the coronavirus crisis High-Tech Gründerfonds (HTGF) and Evonik Venture Capital have exited Finnish start-up Synoste Oy. US based Globus Medical (NYSE: GMED) acquired all shares. Hig
1. October 2020

Neuromodulation pioneer WISE closes EUR 15M Series C financing round
to launch second product, SCS EXPERT, for chronic pain

SCS EXPERT - first expandable percutaneous lead for neuromodulation treatment of chronic painNew investors, CDP Venture Capital and Eureka!, join existing participating investors in financing roundAdds to EUR 2.3M grant earlier in 2020 from the European Commission to launch SCS EXPERT WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the closing of a EUR 15 million Series C fi